Chilet-Rosell et al. BMC Public Health 2010, 10:134 http://www.biomedcentral.com/1471-2458/10/134 Page 6 of 9 Table 2 Compliance with Farmaindustria’s “Code of Good Practice for the Promotion and Use of Medicines” on non- corporate web pages (Information and Forums) promoting the best-selling HRT drugs in Spain. Registered name/Co address Data Sheet Indications Erroneous Indications References Differentiated patient physician information Portal/HRT drug http://www.dkvseguros.com (*): Absorlent Plus http://www.nomenclator.org (*): Absorlent Plus, Activelle, Duofemme, Estalis, Merigest, Perifem http://www.vademecum.es (*): Absorlent Plus, Activelle, Duofemme, Estalis, Estracomb, Merigest, Perifem, Progyluton http://www.epgonline.org (*): Absorlent Plus http://www.farmacopedia.com (*): Absorlent Plus, No Activelle http://www.diagnosticomedico.es (*): Absorlent No Plus, Activelle, Estalis Merigest, Perifem http://www.prospectos.net (*): Activelle No http://www.agemed.es (*): Activelle, Duofemme, Merigest, Perifem, Progyluton http://www.laboratoriosilesia.com (*): Activelle http://www.novasalud.cl (*): Activelle http://www.solucionestraumatologicas.com (*): Activelle http://www.concursossanitarios.com/(*): Duofemme, Merigest, Perifem http://www.famguerra.com (*): Estalis, Estracomb http://www.medbroadcast.com (*): Estalis, Estracomb http://www.novartis.ca (*): Estalis, Estracomb http://www.facmed.unam.mx (*): Estalis, Estracomb http://www.saludzac.gob.mx (*): Estalis http://www.rxmed.com (*): Estracomb http://www.pdamecum.com (*): Estracomb http://www.healthyontario.com (*): Estracomb http://chealth.canoe.ca/(*): Perifem http://www.hipocrates.com (*): Progyluton http://www.cmp-sanmartin.org (*): Duofemme, Perifem, Progyluton http://www.enfemenino.com (**): Perifem, Progyluton Yes No Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes No Yes Yes Yes No Yes No. No No No No No No No Yes No No No No Yes No Yes No No Yes Yes No No No No No No No Yes Yes No No Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Osteoporosis unspecific prevention Osteoporosis unspecific prevention Osteoporosis unspecific prevention Osteoporosis unspecific prevention Osteoporosis unspecific prevention Osteoporosis unspecific prevention Menstrual cycle Regulation/ osteoporosis Prevention Menstrual cycle Regulation No No No No No No Yes No No Yes No No No No No No No No No No No No No No No. Must consult a doctor Yes, but does not require professional body membership number No. Must consult a professional No Yes, but does not require professional body membership number Yes, but does not require professional body membership number Yes, but does not require professional body membership number No. Must consult a professional Yes, but does not require professional body membership number No. Must consult a professional Yes, but does not require professional body membership number No. Must consult a professional No No No No No No No No No No No No